Israeli startup CytoReason has made its entry into Japan – the world's third-largest pharmaceutical market, upon signing a collaboration with Summit Pharmaceuticals International, the drug research and development arm of Sumitomo Corporation, one of the world's biggest general trading firms.
WHAT THEY DO
CytoReason develops computational disease models for drug discovery and development using...
Greek startup Intelligencia has received €10.2 million ($12M) of Series A funding in a round led by European health tech investor MTIP.
Previous seed-round investors, the Greek Big Pi Ventures and Synetro Group, also participated and were joined by global professional services firm ZS.
Intelligencia will also partner with ZS, which will use its platform to help accelerate its ability to...
As the world begins to see a light at the end of the COVID-19 tunnel, healthcare leaders have begun strategizing on how to take the lessons learned and apply them to a post-pandemic environment.
“What we really want to be able to do is leverage many of those learnings that we garnered from this experience and really institutionalize those in the health system as we move forward, and how we...
A new platform aimed at streamlining clinical trials in order to lower costs – and increase the efficiency and success rate of a drug or the development of a medical device – has been unveiled by Ben-Gurion University of the Negev (BGU).
The yet-to-be-named programme reportedly “leverages machine learning to optimise a clinical trial’s chances of success” through the analysis of factors including...
On Tuesday, life sciences company LabCorp announced a new technology platform to help streamline the clinical trial and drug development process.
The platform was designed for LabCorp’s drug development and decentralized clinical trial business, Covance. It hopes to more easily connect patients to trials, decrease administrative tasks, improve trial resiliency and enhance studies through the use...
Clinical lab and drug development giant LabCorp announced this morning a new deal that will streamline its adoption of virtual clinical trials.
The company's drug-development-focused contract research organization (CRO), Covance, will use digital clinical trial software-maker Medable's platform to fuel its patient and site interface. This will allow participants easy access to clinical trial apps...
German pharma giant Bayer and British biotech firm Exscientia have announced a three-year partnership focused on the use of Artificial Intelligence in cardiovascular and oncology drug discovery.
The collaboration will initially see the companies work on three early-stage research projects, combining Bayer’s data and drug discovery capabilities and Exscientia’s Centaur Chemist platform.
According...
The FDA and National Institutes of Health are tapping the clinical community and a newly launched mobile platform in its search for novel infectious disease interventions.
Called CURE ID, the online data repository will allow clinicians to report instances in which existing FDA-approved drugs are used to successfully treat infections.
In particular, the tool captures clinical outcomes in cases...
Litmus Health announced yesterday the release of a new version of its device-friendly clinical research platform for the collection and analysis of real-world data.
Built with new features to help pharmaceutical companies from the beginning to the end of their drug trials, the platform now adds Actigraph’s medical-grade wearables to its repertoire of supported devices, which previously included...
Last week, Eko Devices announced a new service that matches ECG and heart sound recordings with clinical data to help pinpoint novel drug-data combinations. The Silicon Valley startup is pitching the platform, called Eko Home, as a resource for clinical trials targeting new therapies.
The new platform is already seeing some action. According to the company, an ongoing Mayo Clinic study exploring...
_21.jpg?itok=apOB88-O "The funds will be used for product development and building customer-facing teams.")
.jpg?itok=MZ_RxCEv "The yet-to-be-named programme reportedly “leverages machine learning to optimise a clinical trial’s chances of success” through the analysis of factors such as patient population recruitment and dropout rate.")
